Urinary lysosomal enzyme excretion in pregnant women with hypertensive disorders

References

• ACOG. Diagnosis and management of preeclampsia et eclampsia. ACOG Pract Bull 2002;33:1–14
   Google Scholar
• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7
   PubMed Web of Science ®Google Scholar
• Szczepaniak-Chicheł L, Tykarski A. Treatment of arterial hypertension in pregnancy in relation to current guidelines of the Polish Society of Arterial Hypertension from 2011. Ginekol Pol 2012;83:778–83
   PubMedGoogle Scholar
• Magee LA, Helewa M, Moutquin JE, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynecol Can 2008;39:s1–48
   Google Scholar
• Lindheimer MD, Taler SJ, Cunningham GC. Hypertension in pregnancy. J Am Soc Hypertens 2008;2:484–94
   PubMed Web of Science ®Google Scholar
• Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Perinatol. 2012. [Epub ahead of print]. doi:10.1155/2012/105918
   Google Scholar
• Szymula D, Poniedziałek-Czajkowska E, Laskowska M, Oleszczuk J. Nadzór nad ciążą powikłaną preeklampsją i nadciśnieniem przewlekłym. Klin Perinatol Ginekol 2006;42:40–6
   Google Scholar
• Wu Y, Xiong X, Fraser WD, Luo ZC. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. Am J Hypertens 2012;25:711–17
   PubMed Web of Science ®Google Scholar
• Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol 2000;95:24–8
   Google Scholar
• Moura SB, Lopes LM, Murthi P, da Silva Costa F. Prevention of preeclampsia. J Pregnancy. 2012. [Epub ahead of print]. doi:10.1155/2012/435090
   Google Scholar
• Briceño-Pérez C, Briceño-Sanabria L, Vigil-De Gracia P. Prediction and prevention of preeclampsia. Hypertens Pregnancy 2009;28:138–55
   PubMed Web of Science ®Google Scholar
• Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy National Institutes of Health National Heart, Lung, and Blood Institute NIH Publication No. 00-3029 (revised July 2000)
   Google Scholar
• Grzywanowska-Łaniewska I, Dłużniewski M, Kuch M. Nadciśnienie tętnicze w ciąży – patofizjologia i aktualna klasyfikacja. Pol Przegl Kardiol 2011;13:165–70
   Google Scholar
• Paternoster DM, Stella A, Babbo GL, et al. Markers of tubular damage in pre-eclampsia. Minerva Ginecol 1999;51:373–7
   PubMedGoogle Scholar
• Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007;18:2281–4
   PubMed Web of Science ®Google Scholar
• Liangos O, Perianayagam MC, Vaidya VS. Urinary N-acetyl-β-(d)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007;18:904–12
   PubMed Web of Science ®Google Scholar
• Price N. The role of NAG in the diagnosis of kidney disease including the monitoring of nefrotoxicity. Clin Nephrol 1992;1:14–19
   Google Scholar
• Marshall P, Goren MP, Sibai BM, el-Nazar A. Increased tubular enzyme excretion in preeclampsia. Am J Obstet Gynecol 1987;7:906–8
   Google Scholar
• Perez-Blanco FJ, Sanabria MC, Huertas JM, et al. Urinary N-acetyl-β-d-glucosaminidase in the prediction of preeclampsia. Clin Nephrol 1998;50:169–71
   PubMedGoogle Scholar
• Hayashi M, Ueda Y, Hoshimoto K, et al. Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia. Am J Kidney Dis 2002;39:392–400
   PubMed Web of Science ®Google Scholar
• Semczuk-Sikora A, Sikora P, Semczuk M. Urinary N-acetyl-β-d-glucosaminidase (NAG) activity in women with preeclampsia. Ginekol Pol 2000;71:141–5
   PubMedGoogle Scholar
• Borenstein R, Rozenman D, Lancet M, et al. Significance of urinary enzymes in gestosis. Gynecol Obstet Invest 1979;10:193–203
   PubMedGoogle Scholar
• Jackson DW, Sciscione A, Hartley TL, et al. Lysosomal enzymuria in preeclampsia. Am J Kidney Dis 1996;27:826–33
   PubMedGoogle Scholar
• Refaie MO, Abo-Zaid H, Gomma NA, Aboul-Enein HY. Determination of urinary and serum beta-glucuronidase and alkaline phosphatase in various renal disease and kidney rejection transplanted patients. Prep Biochem Biotechnol 2000;30:93–106
   PubMed Web of Science ®Google Scholar
• Floriańczyk B, Semeniuk A, Kątska M, et al. β-Glucoronidase in the blood serum and urine of children with urinary tract infection. Ann Univ Mariae Curie Sklodowska 2005;60:452–7
   Google Scholar
• Karmowski A, Sobiech KA, Bakońska-Pacoń E, et al. Aktywność arylosulfatazy A (EC 3.1.6.1) w surowicy, moczu i płynie owodniowym kobiet ciężarnych z EPH-gestozą. Ginekol Pol 2000;70:495–9
   Google Scholar
• Glew RH, Cole DM, Mehla GS, et al. Lysosomal enzymes in preeclamptic women in northern Nigeria. Clin Chim Acta 2005;353:95–101
   PubMedGoogle Scholar
• Semczuk-Sikora A, Sikora P, Biaduń U, Semczuk M. Urinary N-acetyl-beta-d-glucosaminidase (NAG) excretion in women with pregnancy complicated with hypertension. Ginekol Pol 2003;74:1269–75
   PubMedGoogle Scholar
• Hennessy A, Markis A. Preeclamptic nephropathy. Nephrology 2011;16:134–43
   PubMed Web of Science ®Google Scholar
• Kaplan AA, Kohn OF. Fractional excretion of urea as a guide to renal dysfunction. Am J Nephrol 1992;12:49–54
   PubMed Web of Science ®Google Scholar
• Racusen LC. The morphologic basis of acute renal failure. In: Molitoris BA, Finn WF, eds. Acut renal failure. Philadelphia: W.B. Saunders; 2001:1–12
   Google Scholar
• Doi K, Katagiri D, Negishi K, et al. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int 2012;82:1114–20
   PubMed Web of Science ®Google Scholar
• Peto K, Olah Va, Brath E, et al. Determination of urinary NAG to detect renal ischemia-reperfusion injury and the protective effect of allopurynol. Magy Seb 2005;58:134–7
   PubMedGoogle Scholar
• Herget-Rosenthal S, Poppen D, Husing J, et al. Prognostic value of tubular proteinurua and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2003;50:552–8
   Google Scholar
• Harvey C. Gonick, Herbert J. Kramer, Arthur E. Schapiro. Urinary β-glucuronidase activity in renal disease. Arch Intern Med 1973;132:63–9
   Google Scholar
• Patel V, Luft F, Nahm Yum U, et al. Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother 1975;3:364–9
   Google Scholar
• Prabal K Chatterjee, Salvatore Cuzzocrea, Paul AJ Brown, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 2000;58:658–73
   PubMedGoogle Scholar
• Mohamadin AM, El-Beshbishy HA, El-Mahdy MA. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol Res 2005;51:51–7
   PubMed Web of Science ®Google Scholar
• Bazzi C, Petrini C, Rizza V, et al. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890–6
   PubMed Web of Science ®Google Scholar